Indoco Remedies Q2 FY27 Results (NSE: INDOCO)

· Analysis by Alpha Inflection

Signal: Loss reversed

The read

The operating recovery is incomplete: consolidated revenue reached ₹50,692 lakh, +7.4% YoY, and EBITDA margin improved to 9.2%, but pre-exceptional PBT remained a ₹2,295 lakh loss and PAT of ₹1,947 lakh depended on the ₹3,714 lakh property-sale gain. This follows the prior quarter's 9% margin, so the margin recovery has stabilized rather than clearly re-accelerated.

Indoco Remedies Q2 FY27 key financials
MetricValueYoYQoQ
Revenue₹506.92 Cr+7.4%+8.7%
EBIT₹11.99 CrTurned positive from loss
Net profit₹19.47 CrTurned profitable from ₹924 lakh loss
EPS₹2.11Turned positive from loss
EBIT margin9.2%

P&L walk

Consolidated revenue increased to ₹50,692 lakh, +7.4% YoY and +8.7% QoQ, while EBITDA rose to ₹4,643 lakh and margin reached 9.2%; however, EBIT before exceptional items remained a ₹2,295 lakh loss and PAT of ₹1,947 lakh was primarily enabled by the ₹3,714 lakh property-sale gain.

Segments

Domestic revenue drove the group with ₹33,577 lakh and +10.6% YoY growth, while outside-India revenue grew only 1.8% YoY at ₹17,115 lakh; standalone PAT of ₹3,063 lakh was ₹1,116 lakh above consolidated PAT, indicating subsidiary drag on group earnings.

Key positives

Key concerns

View original filing

Research and educational content only. Not investment advice.